Limestone Investment Advisors’s Gilead Sciences GILD Stock Holding History

Limestone Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$331K	Buy	+2,620	New	+$345K	0.02%	366

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Limestone Investment Advisors's GILD Position: Q2 2026 in Review

Limestone Investment Advisors opened a new position in Gilead Sciences (GILD) in Q2 2026: 2,620 shares worth $331K. The stake represents 0.02% of the portfolio and ranks #366 among its holdings.

2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Limestone Investment Advisors held 2,620 shares of Gilead Sciences worth $331K as of Q2 2026.
Gilead Sciences was a new Limestone Investment Advisors position in Q2 2026.
Gilead Sciences made up 0.02% of Limestone Investment Advisors's portfolio in Q2 2026, its #366 holding.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Limestone Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.